Bovine β-Casein (1−28), a Casein Phosphopeptide, Enhances Proliferation and IL-6 Expression of Mouse CD19+ Cells via Toll-like Receptor 4
This study was conducted to elucidate the target cells and receptors which participate in the mitogenic and interleukin (IL)-6-enhancing effect of bovine β-casein (1−28), a casein phosphopeptide. When the spleen lymphocyte subset (CD4+, CD8+, and CD19+ cells) from C3H/HeN mice was cultured with the...
Saved in:
Published in | Journal of agricultural and food chemistry Vol. 54; no. 21; pp. 8013 - 8017 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Chemical Society
18.10.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This study was conducted to elucidate the target cells and receptors which participate in the mitogenic and interleukin (IL)-6-enhancing effect of bovine β-casein (1−28), a casein phosphopeptide. When the spleen lymphocyte subset (CD4+, CD8+, and CD19+ cells) from C3H/HeN mice was cultured with the β-casein (1−28), it exerted a dose-dependent mitogenic effect on CD19+ cells. The effect of β-casein (1−28) was not apparent in the case of CD19+ cells from C3H/HeJ mouse. In addition, the effect was significantly inhibited by treating the C3H/HeN mouse-derived CD19+ cells with neutralizing antibody for toll-like receptor 4 (TLR4). Reverse transcription-polymerase chain reaction analysis showed that the β-casein (1−28) exerted an IL-6-enhancing effect on the CD19+ cells. The effect was also abrogated in either C3H/HeJ mouse-derived CD19+ cell culture or the anti-TLR4 antibody-added culture. These results suggest that the β-casein (1−28) stimulates both proliferation and IL-6 expression of CD19+ cells via TLR4. Keywords: Casein phosphopeptide; milk; mitogenic activity; CD19+ cells; IL-6; toll-like receptor 4 |
---|---|
Bibliography: | istex:DC73C1B8A33DF97539BD802B352CEA9B6DDAD665 ark:/67375/TPS-GV9769XZ-8 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0021-8561 1520-5118 |
DOI: | 10.1021/jf0610864 |